201 related articles for article (PubMed ID: 34963505)
1. Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020-2021.
Nicolete VC; Rodrigues PT; Fernandes ARJ; Corder RM; Tonini J; Buss LF; Sales FC; Faria NR; Sabino EC; Castro MC; Ferreira MU
Emerg Infect Dis; 2022 Mar; 28(3):709-712. PubMed ID: 34963505
[TBL] [Abstract][Full Text] [Related]
2. Cluster of SARS-CoV-2 Gamma Variant Infections, Parintins, Brazil, March 2021.
da Silva JF; Esteves RJ; Siza C; Soares EP; Ramos TC; Campelo EC; da Costa CF; de Alencar LC; Cavalcante RP; Florêncio CR; Mattos TP; Bonecini-Almeida MG; Silva-Flannery L; Marston BJ; Morgan J; Plucinski M; Naveca F;
Emerg Infect Dis; 2022 Jan; 28(1):262-264. PubMed ID: 34856111
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence and risk factors for COVID-19 in the metropolis of the Brazilian Amazon.
da Silva Torres MK; Lopes FT; de Lima ACR; Lima CNC; Dos Santos Brito WR; Dos Santos BC; de Sousa RS; Gomes JLC; Botelho BJS; Correa ACA; Machado LFA; Feitosa RNM; Lima SS; Vallinoto IMVC; Vallinoto ACR
Sci Rep; 2022 May; 12(1):8571. PubMed ID: 35595782
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil.
Chaves DG; Takahashi RHC; Campelo F; da Silva Malta MCF; de Oliveira IR; Barbosa-Stancioli EF; Ribeiro MA; Martins ML
Emerg Infect Dis; 2022 Apr; 28(4):734-742. PubMed ID: 35180375
[TBL] [Abstract][Full Text] [Related]
5. Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon.
Ndongo FA; Guichet E; Mimbé ED; Ndié J; Pelloquin R; Varloteaux M; Esemu L; Mpoudi-Etame M; Lamare N; Edoul G; Wouambo RK; Djomsi DM; Tongo M; Tabala FN; Dongmo RK; Diallo MSK; Bouillin J; Thaurignac G; Ayouba A; Peeters M; Delaporte E; Bissek AZ; Mpoudi-Ngolé E
Emerg Infect Dis; 2022 Jun; 28(6):1233-1236. PubMed ID: 35470795
[TBL] [Abstract][Full Text] [Related]
6. Large-Scale Screening of Asymptomatic Persons for SARS-CoV-2 Variants of Concern and Gamma Takeover, Brazil.
Adamoski D; de Oliveira JC; Bonatto AC; Wassem R; Nogueira MB; Raboni SM; da Silva Trindade E; de Souza EM; Gradia DF; ;
Emerg Infect Dis; 2021 Dec; 27(12):3124-3127. PubMed ID: 34533453
[TBL] [Abstract][Full Text] [Related]
7. Clinical and epidemiological aspects of Delta and Gamma SARS-CoV-2 variant of concern from the western Brazilian Amazon.
Sgorlon G; Queiroz JADS; Roca TP; Silva AMPD; Gasparelo NWF; Teixeira KS; Oliveira ASDN; Mendonça ALFM; Maia ACS; Pereira SDS; Batista FS; Salcedo JMV; Rampazzo RCP; Resende PC; Siqueira MM; Naveca FG; Vieira D
Mem Inst Oswaldo Cruz; 2023; 117():e220155. PubMed ID: 36700580
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study.
Lalwani P; Salgado BB; Filho IVP; da Silva DSS; de Morais TBDN; Jordão MF; Barbosa ARC; Cordeiro IB; Neto JNS; de Assunção EN; Dos Santos RO; Carvalho NO; Sobrinho WBS; da Costa CF; de Souza PE; de Albuquerque BC; Ganoza CA; Araujo-Castillo RV; Filho SA; Lalwani JDB;
Int J Infect Dis; 2021 Sep; 110():141-150. PubMed ID: 34273518
[TBL] [Abstract][Full Text] [Related]
9. Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan.
Fujino T; Nomoto H; Kutsuna S; Ujiie M; Suzuki T; Sato R; Fujimoto T; Kuroda M; Wakita T; Ohmagari N
Emerg Infect Dis; 2021 Apr; 27(4):1243-5. PubMed ID: 33567247
[TBL] [Abstract][Full Text] [Related]
10. Emergence of SARS-CoV-2 Delta Variant, Benin, May-July 2021.
Yadouleton A; Sander AL; Adewumi P; de Oliveira Filho EF; Tchibozo C; Hounkanrin G; René KK; Ange D; Kohoun RK; Nari RC; Salifou S; Saizonou R; Kakai CG; Bedié SV; Al Onifade F; Nagel M; Aïssi MAJ; Akogbeto P; Drosten C; Wulf B; Moreira-Soto A; Djingarey MH; Hounkpatin B; Drexler JF
Emerg Infect Dis; 2022 Jan; 28(1):205-209. PubMed ID: 34807815
[TBL] [Abstract][Full Text] [Related]
11. Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021.
Vignier N; Bérot V; Bonnave N; Peugny S; Ballet M; Jacoud E; Michaud C; Gaillet M; Djossou F; Blanchet D; Lavergne A; Demar M; Nacher M; Rousset D; Epelboin L
Emerg Infect Dis; 2021 Oct; 27(10):2673-2676. PubMed ID: 34289335
[TBL] [Abstract][Full Text] [Related]
12. Changes in the seroprevalence and risk factors between the first and second waves of COVID-19 in a metropolis in the Brazilian Amazon.
da Silva Torres MK; Lopes FT; de Lima ACR; Cordeiro Lima CN; Dos Santos Brito WR; Gonçalves JSS; Dos Santos Oliveira O; de Oliveira Freitas V; Dos Santos BC; Santos de Sousa R; Carvalho Gomes JL; Sarmento Botelho BJ; Alves Correa AC; Machado LFA; Martins Feitosa RN; Lima SS; Cayres Vallinoto IMV; Vallinoto ACR
Front Cell Infect Microbiol; 2022; 12():932563. PubMed ID: 36189360
[TBL] [Abstract][Full Text] [Related]
13. Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy.
Maggi F; Novazzi F; Genoni A; Baj A; Spezia PG; Focosi D; Zago C; Colombo A; Cassani G; Pasciuta R; Tamborini A; Rossi A; Prestia M; Capuano R; Azzi L; Donadini A; Catanoso G; Grossi PA; Maffioli L; Bonelli G
Emerg Infect Dis; 2021 Apr; 27(4):1249-1251. PubMed ID: 33567246
[TBL] [Abstract][Full Text] [Related]
14. Migration in times of pandemic: SARS-CoV-2 infection among the Warao indigenous refugees in Belém, Pará, Amazonia, Brazil.
da Silva HP; Abreu IN; Lima CNC; de Lima ACR; do Nascimento Barbosa A; de Oliveira LR; Fujishima MA; Lima SS; de Lima VN; Castelo-Branco S; Vallinoto ACR
BMC Public Health; 2021 Sep; 21(1):1659. PubMed ID: 34511064
[TBL] [Abstract][Full Text] [Related]
15. Persistence of SARS-CoV-2-Specific IgG in Children 6 Months After Infection, Australia.
Toh ZQ; Higgins RA; Do LAH; Rautenbacher K; Mordant FL; Subbarao K; Dohle K; Nguyen J; Steer AC; Tosif S; Crawford NW; Mulholland K; Licciardi PV
Emerg Infect Dis; 2021; 27(8):2233-2235. PubMed ID: 34016252
[TBL] [Abstract][Full Text] [Related]
16. Mutations Associated with SARS-CoV-2 Variants of Concern, Benin, Early 2021.
Sander AL; Yadouleton A; de Oliveira Filho EF; Tchibozo C; Hounkanrin G; Badou Y; Adewumi P; René KK; Ange D; Sourakatou S; Sedjro E; Aïssi MAJ; Fidelia H; Djingarey MH; Nagel M; Jo WK; Moreira-Soto A; Drosten C; Landt O; Corman VM; Hounkpatin B; Drexler JF
Emerg Infect Dis; 2021 Nov; 27(11):2889-2903. PubMed ID: 34463240
[TBL] [Abstract][Full Text] [Related]
17. Age-Associated Seroprevalence of Coronavirus Antibodies: Population-Based Serosurveys in 2013 and 2020, British Columbia, Canada.
Tanunliong G; Liu AC; Kaweski S; Irvine M; Reyes RC; Purych D; Krajden M; Morshed M; Sekirov I; Gantt S; Skowronski DM; Jassem AN
Front Immunol; 2022; 13():836449. PubMed ID: 35401521
[TBL] [Abstract][Full Text] [Related]
18. Anti-SARS-CoV-2 antibodies among indigenous populations of the Brazilian Amazon: a cross-sectional study.
Lima CNC; Abreu IN; Rodrigues EPS; Freitas VO; Botelho BJS; Souza SL; Cayres-Vallinoto I; Guerreiro JF; Ishak R; Vallinoto ACR
BMJ Open; 2022 Feb; 12(2):e054271. PubMed ID: 35131827
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Seroprevalence before Delta Variant Surge, Chattogram, Bangladesh, March-June 2021.
Bhuiyan TR; Hulse JD; Hegde ST; Akhtar M; Islam T; Khan ZH; Khan II; Ahmed S; Rashid M; Rashid R; Gurley ES; Shirin T; Khan AI; Azman AS; Qadri F
Emerg Infect Dis; 2022 Feb; 28(2):429-431. PubMed ID: 35076007
[TBL] [Abstract][Full Text] [Related]
20. Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020-March 2022.
Yamayoshi S; Iwatsuki-Horimoto K; Okuda M; Ujie M; Yasuhara A; Murakami J; Duong C; Hamabata T; Ito M; Chiba S; Kobayashi R; Takahashi S; Mitamura K; Hagihara M; Shibata A; Uwamino Y; Hasegawa N; Ebina T; Izumi A; Kato H; Nakajima H; Sugaya N; Seki Y; Iqbal A; Kamimaki I; Yamazaki M; Kawaoka Y; Furuse Y
Emerg Infect Dis; 2022 Nov; 28(11):2198-2205. PubMed ID: 36198306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
